German biotech firm BioNTech (22UAy.DE), has agreed to acquire domestic peer CureVac, for about $1.25 billion worth of BioNTech shares, it said on Thursday, to boost its work on new mRNA-based cancer treatments.
Under the deal, which pairs two former rivals in the race to develop COVID-19 vaccines, CureVac shareholders stand to receive a premium of 55% over the three-month average share price, and leave them with a stake of about 4%-6% in BioNTech, the suitor said.
CureVac's Frankfurt-listed shares surged 27% to a five-month high, valuing the company at €1.04 billion ($1.2 billion), while BioNTech shares were down 2%.
The deal further underscores BioNTech's long-term pursuit of new cancer treatments as it aims to show that its success as Pfizer's COVID-19 vaccine partner, which left its balance sheet flush with billions of euros in cash, was not a fluke.
"With the acquisition, BioNTech aims to strengthen the research, development, manufacturing, and commercialization of investigational mRNA-based cancer immunotherapy," the company said.
CureVac opted to focus on oncology about a year ago when it agreed to sell its remaining influenza and COVID-19 vaccine development to alliance partner GSK.
It had previously cut jobs as it sought to move beyond its failure to develop an mRNA-based COVID vaccine during the pandemic.
GERMAN BIOTECH CHAMPION
The agreement is also set to end CureVac's years-long legal fight over alleged mRNA patent infringement by BioNTech and for a share of vaccine revenues, where CureVac has made little progress.
CureVac shares were worth as much as €120 in December 2020 on hopes it would develop a COVID vaccine, more than double their initial public offer value in August of that year. They are now trading at €4.65.
BioNTech won a major shot in the arm for its cancer drug activities last week when Bristol Myers Squibb agreed to pay up to $11.1 billion to jointly develop a next-generation cancer immunotherapy that could take on rival Merck & Co's best-selling drug Keytruda.
Each CureVac share will be exchanged for about $5.46 in BioNTech American depositary shares, or ADS, but subject to a so-called collar mechanism, BioNTech said.
If the 10-day volume-weighted average price of BioNTech ADS shortly before the closing of the offer exceeds $126.55, the exchange ratio would be 0.04318, and if the price is lower than $84.37, the exchange ratio would be 0.06476.
BioNTech said the deal was supported by SAP SE co-founder and football investor Dietmar Hopp, who holds a stake of about 37% in CureVac.
The German government, owner of about 13% in CureVac for its financial backing during the pandemic, said it welcomed in principle the creation of a "new German biotech champion", and that it would review the offer.
The U.S. FDA has approved Moderna’s next-generation COVID-19 vaccine, mNEXSPIKE, for adults aged 65 and older and those aged 12–64 with risk factors, marking a major step under tighter regulations.
The Centers for Disease Control and Prevention (CDC) confirmed Friday that COVID-19 vaccines are still recommended for healthy children aged 6 months and older—if their doctors agree.
U.S. Health Secretary Robert F. Kennedy Jr. has announced that COVID-19 vaccines will no longer be recommended for healthy children and pregnant women — a move that has sparked sharp criticism from public health experts.
Southeast Asia is witnessing a renewed surge in COVID-19 infections, with Singapore, Hong Kong, China, and Thailand all reporting sharp increases, raising concerns about a possible new wave of the virus across the region.
In January 2025, the CIA made headlines by revising its position on the origins of COVID-19, now favoring the laboratory leak theory over natural origins.
UN Security Council hears Israel and Iran clash over recent nuclear strikes, with both sides presenting sharply opposing views amid growing regional tensions.
Iran launched a third wave of missile attacks early Saturday, targeting Tel Aviv and Ramat Gan, with several buildings reportedly destroyed, according to Israeli media.
Israeli airstrikes have hit an area near Mehrabad Airport in western Tehran.
Israel struck the Shahid Raisi Nuclear Power Plant in Isfahan early Saturday, according to Iran’s state news agency IRNA.
Israel’s military confirmed early Saturday that Iran launched a new wave of missiles toward the country, triggering sirens and explosions across multiple areas.
Start your day informed with AnewZ Morning Brief: here are the top news stories for June 8th, covering the latest developments you need to know.
Pakistan will begin its first freight train service to Russia from Lahore on June 22. The route is part of the INSTC and aims to connect Pakistan's rail network with Central Asia, establishing a new trade corridor via Iran, Turkmenistan, and Kazakhstan.
Presidential candidate Miguel Uribe Turbay is in critical condition after being shot three times — including twice in the head — during a campaign event in Bogotá.
Kazakhstan and the UK are strengthening defense ties with a new Military Cooperation Plan, focusing on peacekeeping and military education.
A 30-year-old woman was shot by police in Munich on Saturday evening after stabbing two people at Theresienwiese, a central park best known for hosting Oktoberfest.
Revolutionizing Heart Care: How Artificial Intelligence Powered Digital Twins Are Shaping the Future of Medicine
Researchers at the University of Miami have discovered 230 new giant viruses in global ocean waters, shedding light on their hidden role in marine ecosystems and their potential impact on public health.
Mayo Clinic researchers have validated a blood test's high precision for diagnosing patients with cognitive impairment.This non-invasive, cost-effective breakthrough, detailed in Alzheimer's & Dementia, offers much-needed hope for earlier intervention and better management.
US President Donald Trump signed an executive order Friday to ease restrictions on American drones and help the industry compete with China.
Vietnam has officially abolished its long-standing two-child policy in a bid to counter declining birth rates and a shrinking workforce.
UN Security Council hears Israel and Iran clash over recent nuclear strikes, with both sides presenting sharply opposing views amid growing regional tensions.
Iran launched a third wave of missile attacks early Saturday, targeting Tel Aviv and Ramat Gan, with several buildings reportedly destroyed, according to Israeli media.
Israeli airstrikes have hit an area near Mehrabad Airport in western Tehran.
Israel struck the Shahid Raisi Nuclear Power Plant in Isfahan early Saturday, according to Iran’s state news agency IRNA.
Israel’s military confirmed early Saturday that Iran launched a new wave of missiles toward the country, triggering sirens and explosions across multiple areas.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment